Frankfurt am Main, Germany | AFP | Fears that cash-rich corporate raiders could use the coronavirus crisis to swoop on weakened European firms were perhaps best exemplified by Donald Trump’s alleged bid for a German biotech firm working on a vaccine. The outrage that followed has spurred fresh action by European …
Read More »